Co-Authors
This is a "connection" page, showing publications co-authored by Christopher Duncan and Patrick Lillie.
Connection Strength
0.567
-
Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission. J Infect. 2020 05; 80(5):578-606.
Score: 0.217
-
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. PLoS One. 2011; 6(7):e22271.
Score: 0.120
-
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021 04 10; 397(10282):1351-1362.
Score: 0.059
-
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
Score: 0.058
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
Score: 0.057
-
COVID-19: public health management of the first two confirmed cases identified in the UK. Epidemiol Infect. 2020 08 28; 148:e194.
Score: 0.056